Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neuphoria Therapeutics (NEUP) Net Margin (2024 - 2025)

Historic Net Margin for Neuphoria Therapeutics (NEUP) over the last 2 years, with Q2 2025 value amounting to 114247.12%.

  • Neuphoria Therapeutics' Net Margin changed N/A to 114247.12% in Q2 2025 from the same period last year, while for Dec 2025 it was 80.12%, marking a year-over-year increase of 3310600.0%. This contributed to the annual value of 42.45% for FY2025, which is N/A changed from last year.
  • Per Neuphoria Therapeutics' latest filing, its Net Margin stood at 114247.12% for Q2 2025.
  • In the past 5 years, Neuphoria Therapeutics' Net Margin ranged from a high of 114247.12% in Q2 2025 and a low of 289.74% during Q4 2024